- Raised $978k Undisclosed Round led by PipelBiz, Mar 2025
- Raised Undisclosed Round led by PipelBiz, Mar 2024
About
Cell-Lipo is an Israeli company developing a medical device platform that transforms adipose tissue into a reproducible, high-viability, high-cell-yield regenerative treatment at the point of care. Their technology focuses on laser-assisted liposuction and stem cell isolation for enhanced fat grafting and other non-aesthetic clinical applications, aiming to provide accessible, science-based regenerative stem cell solutions and improve aesthetic treatments. The company's patented device combines mechanical processing, ultrasonic cavitation, laser-assisted aspiration, and a fiber-trap to deliver high cell viability and consistent stromal vascular fraction (SVF) cell yield. Cell-Lipo's technology is integrated as a closed medical system in a patent-protected device to enable rapid, simple, sterile, and cost-effective isolation of stem cells from fat tissue. This non-enzymatic method reduces tissue damage and aims to be a sustainable alternative to current enzymatic isolation methods. Initial focus markets include joint-pain injections (orthopedics) and long-lasting fat grafts (aesthetics).
Funding history · 2 rounds · $978K total
Headcount over time
Q&A
- What is Cell-Lipo's primary focus?
- Cell-Lipo focuses on personalized cell therapy, providing science-based regenerative stem cell solutions for aesthetic treatments and chronic disorders.
- What technology does Cell-Lipo utilize?
- Cell-Lipo's technology is based on laser liposuction and stem cell isolation for enhanced fat grafting and other non-aesthetic clinical applications. It uses a patent-protected device for rapid, simple, sterile, and cost-effective isolation of stem cells from fat tissue.
- When was Cell-Lipo founded?
- Cell-Lipo was founded in December 2022.
- What is Cell-Lipo's current funding stage?
- Cell-Lipo is currently in the Seed funding stage.
- Has Cell-Lipo secured any funding?
- Yes, Cell-Lipo secured a funding round in April 2024, with PipelBiz as an investor.
- In which sector does Cell-Lipo primarily operate?
- Cell-Lipo's primary sector is Health Tech & Life Sciences.
- What are some applications of Cell-Lipo's technology?
- Beyond aesthetic treatments, Cell-Lipo's technology has applications in orthopedics, specifically for Osteoarthritis and sport injuries.
- Does Cell-Lipo hold any patents?
- Yes, Cell-Lipo holds patents for its technology, with one patent recorded.
Team · 4
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | cell-lipo.com/ |
|---|---|
| linkedin.com/company/86838230 |
Identifiers & details
| Legal name | Cell-Lipo LTD |
|---|---|
| Founded | 2022-12 |
| Employees (exact) | 4 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | cell-lipo.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516728052 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2022-12-27 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 4 — shares_capital (2), other (1), violation (1) |
| Registered address | הכרם 48 כפר מרדכי |
Recent registry events
| Date | Event |
|---|---|
| 2026-01-25 | שינוי בהרכב הון - מניות-פיצול מניה |
| 2026-01-22 | שינוי בתקנון |
| 2026-06-14 | עדכון הפרה |
| 2026-05-06 | הקצאת מניות |